Organization: Health Canada
Year: 2022
Month: February
Request Number: A-2021-000983
Request Summary: Adverse Drug Reactions (ADRs) for Abilify maintena. Report numbers: E2B_03858832, E2B_03865924, E2B_03847919, E2B_03851491, E2B_03851951, E2B_03852045, E2B_03868440, E2B_03950110, E2B_03982907, E2B_03996191. ADRs for Aripiprazole: E2B_03885413, E2B_03885517, E2B_03903766, E2B_03848354, E2B_03919693, E2B_03950595, E2B_03984215, E2B_04035487. ADRs for Brexpiprazole: E2B_04035487, E2B_04049742.
Disposition: Disclosed in part
Number of pages: 626